CSIMarket Company Name, Ticker, Customers, else..
 
Mustang Bio inc   (NASDAQ: MBIO)
 

Mustang Bio Inc's Suppliers Performance

MBIO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
MBIO Costs vs Sales of Suppliers Growth

• More on MBIO Suppliers






Mustang Bio Inc's Comment on Supply Chain


The company utilizes contract manufacturers for its current and potential future non-CAR T products. These manufacturers are subject to periodic and unannounced inspections by the FDA and state agencies to ensure compliance with current Good Manufacturing Practice regulations (cGMP) and other applicable regulations. In Europe, contractors face similar regulatory oversight from EU and member state agencies. The company’s control over third-party manufacturers' compliance is limited to contractual obligations. Non-compliance by these manufacturers could result in product recalls, inventory destruction, production stoppages, and supply disruptions. Changing manufacturers requires approval from the FDA and foreign regulatory authorities, including testing and inspections, which may cause delays. The limited number of qualified manufacturers makes switching difficult or impossible on acceptable terms.

Mustang Bio Inc's Comment on Supply Chain


The company utilizes contract manufacturers for its current and potential future non-CAR T products. These manufacturers are subject to periodic and unannounced inspections by the FDA and state agencies to ensure compliance with current Good Manufacturing Practice regulations (cGMP) and other applicable regulations. In Europe, contractors face similar regulatory oversight from EU and member state agencies. The company’s control over third-party manufacturers' compliance is limited to contractual obligations. Non-compliance by these manufacturers could result in product recalls, inventory destruction, production stoppages, and supply disruptions. Changing manufacturers requires approval from the FDA and foreign regulatory authorities, including testing and inspections, which may cause delays. The limited number of qualified manufacturers makes switching difficult or impossible on acceptable terms.







MBIO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Mustang Bio inc 3.50 0.00 -3.03 4
SUBTOTAL 0.00 0.00 0.00 -


Sources: Mustang Bio inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Mustang Bio inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.